SG Americas Securities’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,571
| Closed | -$31K | – | 2779 |
|
|
2024
Q1 | $31K | Sell |
1,571
-1,799
| -53% | -$35.5K | ﹤0.01% | 2481 |
|
|
2023
Q4 | $70K | Buy |
3,370
+1,972
| +141% | +$41K | ﹤0.01% | 2601 |
|
|
2023
Q3 | $44K | Buy |
+1,398
| New | +$44K | ﹤0.01% | 2662 |
|
|
2022
Q3 | – | Sell |
-385
| Closed | -$15K | – | 3073 |
|
|
2022
Q2 | $15K | Sell |
385
-1,861
| -83% | -$72.5K | ﹤0.01% | 3017 |
|
|
2022
Q1 | $83K | Buy |
2,246
+1,041
| +86% | +$38.5K | ﹤0.01% | 2474 |
|
|
2021
Q4 | $118K | Sell |
1,205
-13,130
| -92% | -$1.29M | ﹤0.01% | 2695 |
|
|
2021
Q3 | $1.79M | Sell |
14,335
-16,933
| -54% | -$2.11M | 0.01% | 1247 |
|
|
2021
Q2 | $3.92M | Buy |
31,268
+22,985
| +277% | +$2.88M | 0.02% | 654 |
|
|
2021
Q1 | $1.12M | Buy |
8,283
+7,754
| +1,466% | +$1.05M | 0.01% | 1313 |
|
|
2020
Q4 | $48K | Buy |
+529
| New | +$48K | ﹤0.01% | 2742 |
|
|
2020
Q3 | – | Sell |
-743
| Closed | -$63K | – | 2779 |
|
|
2020
Q2 | $63K | Buy |
+743
| New | +$63K | ﹤0.01% | 3035 |
|
|
2018
Q1 | – | Sell |
-493
| Closed | -$145K | – | 2854 |
|
|
2017
Q4 | $145K | Buy |
+493
| New | +$145K | ﹤0.01% | 2224 |
|